Current Profile

Rexahn Pharmaceuticals, Inc. (Inactive Symbol)

YTD Price Probability

No random walk data for 2024

Default prediction by Z-Score (what's this?).

Z Score :

9.7152

Sector

Industry

View the other companies in the same industry : Bio Therapeutic Drugs

Alternative Z-Scores designed for non-public companies (i.e. take these with a grain of salt):

For manufacuring companies:

Z' Score :

7.4164

Sector Industry

For non-manufacturing companies:

Z'' Score :

16.6096

Sector Industry

Fundamental Analysis metrics & ratios (what's this?).

Date of financial statements used: 2017-03-31
Book Value:	$1.1M	Internal Value:	$1.1M	Working Capital:	$17.8M
Debt to Asset Ratio:	0.942	Current Ratio:	11.320	Turnover Ratio:	N/A
Net Margin:	N/A	EPS:	-3.400	P/E ratio:	-1.253
P/B ratio:	95.823	ROE:	-7649.6%	ROA:	-441.5%

Symbol: RNN

Market Cap: $108.3M

Exchange: NYSE MKT

Data Since: 2006-01-03